Skip to main content
search
Category

Membership News

Membership NewsMembership News Archive

Oxford Global Events 2023

Oxford Global are hosting several events in 2023 which BIVDA members may be interested in attending. BIVDA members will also receive a discount code for tickets, if you would like to receive this benefit, please email: ben@bivda.org.uk. You can find all the events below:   Spatial Biology Europe 2023: 12 – 13 September 2023 | Amsterdam, Netherlands Spatial Biology Europe…
Dawn
August 4, 2023
Membership NewsMembership News Archive

NHS England AI Diagnostic Fund Webinar – 26 July 2023 – Follow-Up Materials and Recording

  If you missed the NHS England AI Diagnostic Fund webinar on Wednesday 26 July, you can access the recording and slides below. A recording of the session and guidance documentation and slides are now available on the project’s Future NHS workspace at this link: https://future.nhs.uk/aidiagnosticfund/groupHome For general enquires regarding the fund please contact nhsdigital.england.diagnostics_ddcp@nhs.net. For enquiries on the Crown Commercial…
Dawn
August 4, 2023
Membership NewsMembership News Archive

MHRA Standardisation of Genome Amplification Techniques (SoGATs) workshop

The Medicines and Healthcare products Regulatory Agency (MHRA) are hosting a 3-day workshop in London from 4-6 October 2023 on the Standardisation of Genome Amplification Techniques (SoGATs). This is an important event that will help to shape the future of reference materials development. We’d be incredibly grateful if you could help us to promote it to your audiences via your…
Dawn
August 4, 2023
Membership NewsMembership News Archive

Embracing the post-pandemic future: UK in vitro diagnostic testing in 2023 and beyond

  Life changed dramatically in early 2020 as billions were confined to their homes, with the general population regularly using rapid diagnostics for the first time as the sensation of a swab entering our noses became a regular habit. Life has not been the same since. In this article, we examine McKinsey’s report, ‘Rethinking the in vitro diagnostic testing model…
Dawn
August 4, 2023
Membership NewsMembership News Archive

Ashleigh submits article to the Journal of Medical Device Regulation

BIVDA’s Head of Regulatory Affairs, Ashleigh Batchen, has had an article accepted in the August 2023 issue of the Journal of Medical Device Regulation. In the article, ‘The future of in-house test requirements in the EU and the UK’, Ashleigh examines the new IVDR requirements for in-house tests and their timeframes for implementation, including transfer to another legal entity, quality…
Dawn
August 4, 2023
Membership NewsMembership News Archive

DHSC Innovation Classification Roundtable – Implementation – Medical Technology Strategy

BIVDA attended a roundtable event earlier this week which focused on developing the definitions of innovation and proposed classification levels. The roundtable examined a drafted definition for innovation which was good and specific in most areas but was determined to be too broad when referring to “system” and the value of a glossary was noted. The definition should not give…
Ben Kemp
July 28, 2023
Membership NewsMembership News Archive

Second World Local Production Forum (WLPF) this November in The Hague

We would like to highlight the Second World Local Production Forum (WLPF): Enhancing access to medicines and other health technologies to members. The World Local Production Forum (WLPF): Enhancing access to medicines and other health technologies is a WHO initiative providing Member States and the global community a regular platform to shape strategies, galvanize collective action, and foster partnerships on…
Dawn
July 28, 2023
Funding OpportunitiesMembership NewsMembership News Archive

SBRI: Clinical biomarker tools and technologies for dementia

This is a Small Business Research Initiative (SBRI) competition funded by Innovate UK. Organisations can apply for a share of £6 million, inclusive of VAT, to develop or repurpose platform technologies. The aim of the competition is to accelerate innovations in dementia biomarker detection to transform clinical trials and precision therapies. This will be achieved by the development of or repurposing of…
Dawn
July 28, 2023
Close Menu